期刊文献+

人γ-谷氨酰半胱氨酸合成酶催化亚单位基因E-box元件功能初步分析 被引量:2

Preliminary analysis of the E-box element in human γ-glutmylcysteine synthetase catalytic subunit gene
暂未订购
导出
摘要 目的:探讨人支气管上皮细胞γ-谷氨酰半胱氨酸合成酶催化亚单位(GCLC)基因上游调控序列E-box元件的功能。方法:利用PCR法克隆人GCLC基因上游调控序列,PCR重叠延伸法对2个E-box元件分别和同时进行定点突变。扩增获得的突变体片段克隆入PMD18-T载体,DNA测序鉴定后,亚克隆入野生型GCLC-Luc荧光素酶报道载体。将3个突变体质粒和野生型质粒转染人肺泡上皮细胞A549和人支气管上皮细胞16HBE,检测转染后细胞荧光素酶活性值。结果:测序结果证实,成功将E-box1CACGGG突变为AGCGGG;E-box2CACGTG突变为CACGGA。GCLC-Luc、GCLC-mEbox1-Luc(突变E-box1)、GCLC-mEbox2-Luc(突变E-box2)、GCLC-mEbox12-Luc(突变E-box1和E-box2)转染A549细胞后荧光素酶活性值分别为(5197852±132206)U、(5455692±127431)U、(5315722±244197)U、(5174303±183179)U,转染16HBE细胞后荧光素酶活性值分别为(141157±18907)U、(126454±23724)U、(137315±22179)U、(132441±28970)U。经过统计学分析,各组荧光酶活性没有显著差别,均P>0.05。结论:E-box元件不参与基础状态下A549细胞和16HBE细胞GCLC基因转录调控。
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2008年第7期1428-1430,共3页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.30170401) 广东省自然科学基金团队基金资助项目(No.05200239)
关键词 16HBE细胞 A549细胞 基因 GCLC Γ-谷氨酰半胱氨酸合成酶 16HBE cells A549 cells Genes,GCLC Gamma-Glutamy1-cysteine synthetase
  • 相关文献

参考文献7

  • 1Rahman I, MacNee W. Oxidative stress and regulation of glutathione in lung inflammation[ J ]. Eur Respir J ,2000, 16(3) : 534 -554.
  • 2邹朝霞,何志义,冉丕鑫.吸烟对大鼠肺内谷胱甘肽与γ-GCS的影响及乙酰半胱氨酸的干预作用[J].中国病理生理杂志,2007,23(1):86-89. 被引量:10
  • 3Seelig GF. Simondsen RP, Meister A. Reversible dissociation of gamma glutamysysteine synthetase into two subunits[J]. Biol Chem, 1984, 259(15) :9345 -9347.
  • 4Cheng LL, Li B, Luo JD, et al. Identification of E - box motif as transcriptional repressor element in GCLC gene of rat lung epithelial L2 cells [ J ]. Free Radic Biol Med, 2005,39(8) :1030 - 1040.
  • 5J萨姆布鲁克 DW拉塞尔(黄培堂译).分子克隆实验指南[M]第3版[M].北京:科学出版社,2002..
  • 6Rahman I, Smith CA, Lawson MF. Induction of gamma - glutamylcysteine synthetase by cigarette smoke is associated with AP - I in human alveolar epithelial cells [ J ]. FEBS Lett,1996, 396(1): 21 -25.
  • 7Iwanaga M, Moil K, Iida T. Nuclear factor kappa B dependent induction of gamma glutamylcysteine synthetase by ionizing radiation in T98G human glioblastoma cells [ J ]. Free Radic Biol Med, 1998, 24(7-8) :1256- 1268.

二级参考文献10

  • 1Jafari B, Ouyang B, Li LF, et al. Intracellular glutathione in stretch -induced cytokine release from alveolar type -2 like cells[J]. Respirology, 2004, 9(1) : 43 -53.
  • 2Lavrentiadou SN, Chan C, Kawcak T, et al. Ceramide -mediated apoptosis in lung epithelial cells is regulated by glutathione[J]. Am J Respir Cell Mol Biol, 2001, 25(6) : 676 -684.
  • 3O'Donovan DJ, Femandes CJ. Mitochondrial glutathione and oxidative stress: implications for pulmonary oxygen toxicity in premature infants[J]. Mol Genet Metab, 2000,71(1 -2) : 352 -358.
  • 4Rahman I, Smith CA, Lawson MF, et al. Induction of gamma- glutamylcysteine synthetase by cigarette smoke is associated with AP - 1 in human alveolar epithelial cells[J]. FEBS Lett, 1996, 396(1): 21 -25.
  • 5Rahman I, Macnee W. Lung glutathione and oxidative stress: implications in cigarette smoke- induced airway disease[J]. Am J Physiol, 1999, 277 (21): L1067-L1088.
  • 6Grandjean EM, Berthet P, Ruffman R, et al. Efficacy of oral long- term N -acetylcysteine in chronic bronchopulmonary disease: a meta - analysis of published double -blind, placebo - controlled clinical trials [ J ]. Clin Ther,2000, 22(2) : 209 -221.
  • 7Stey C, Steurer J, Bachmann S, et al. The effects of oral N- acetylcysteine in chronic bronchitis: a quantitative systematic review[J]. Eur Respir J, 2000, 16(2) : 253- 262.
  • 8Kasielski M, Nowak D. Long - term administration of N -acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease [ J ].Respir Med, 2001,95(6) : 448 -456.
  • 9Black PN, Morgan -Day A, McMillan TE, et al. Randomised, controlled trial of N - acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease[J]. BMC Pulm Med, 2004, 4(1): 13.
  • 10Decrarner M, Rutten -van Molken M, Dekhuijzen PN, et al. Effects of N - acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Bandomized on NAC Cost - Utility Study, BRONCUS) : a randomised placebo - controlled trial [ J ]. Lancet, 2005, 365 (9470) :1552 - 1560.

共引文献29

同被引文献19

  • 1吴中朝,王玲玲,徐兰风.试论老年人阳虚挟瘀衰老本质[J].江苏中医,1994,15(11):39-40. 被引量:20
  • 2Cai H,Griendling K K,Harrison D G.The vascular NAD(P)H oxidase as therapeutic targets in cardiovascular diseases.Trends Pharmacol Sci,2003,24(9):471-478.
  • 3Bayraktutan U,Blayney L,Shah A M.Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells.Arterioscler Thromb Vasc Biol,2000, 20(8):1903-1911.
  • 4Babior B M.NADPH oxidase.Curr Opin Immtmo,2004,16(1):42-47.
  • 5Lewis R A,Austen K F.Thebiologically active leukotrienes.J Clin Invest,1984,73:889.
  • 6Bayraktutan U,Blayney L,Shah AM.Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells[J].Arterioscler Thromb Vasc Biol,2000 ; 20(8):1903-11.
  • 7Babior BM.NADPH oxidase[J].Curr Opin Immunol,2004;16(1):42-7.
  • 8Kim MJ,Shin KS,Chung YB,et al.Immunohistochemical study of p47Phox and gp91Phox distributions in rat brain[J].Brain Res,2005 ;1040(1- 2):178-86.
  • 9Ambasta RK,Kumar P,Griendling KK,et al.Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase[J].J Biol Chem,2004;279 (44):45935-41.
  • 10Chen W T,et al. A Fast Two-Dimension Entropic Thresholding Algorithm[J]. Pattern Recognition,1994,27(9):885-893.

引证文献2

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部